META, ELDA
 Distribuzione geografica
Continente #
EU - Europa 1.038
AS - Asia 77
NA - Nord America 10
SA - Sud America 6
AF - Africa 2
Totale 1.133
Nazione #
IT - Italia 1.035
SG - Singapore 38
VN - Vietnam 20
CN - Cina 12
US - Stati Uniti d'America 8
AR - Argentina 3
ID - Indonesia 3
BR - Brasile 2
HK - Hong Kong 2
MX - Messico 2
RU - Federazione Russa 2
IN - India 1
IQ - Iraq 1
MA - Marocco 1
PE - Perù 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.133
Città #
Genova 437
Genoa 374
Rapallo 123
Vado Ligure 99
Singapore 13
Ashburn 7
Hanoi 6
Ho Chi Minh City 3
Beijing 2
Haiphong 2
Hong Kong 2
Lấp Vò 2
Biên Hòa 1
Bojonegoro 1
Bordighera 1
Buon Ma Thuot 1
Bắc Ninh 1
Calchaquí 1
Casablanca 1
Chiclayo 1
Durban 1
Greenville 1
Guadalupe 1
Hải Dương 1
Itajaí 1
Khabarovsk 1
Lviv 1
Mexico City 1
Mosul 1
Ninh Bình 1
Nova Olímpia 1
Patiāla 1
San Luis 1
Tasikmalaya 1
Tianjin 1
Torre Annunziata 1
Villa Ángela 1
Totale 1.095
Nome #
The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein Kinase (DMPK)1 as a novel angiogenesis target 153
Pyrazole and imidazo[1,2-b]pyrazole derivatives as new potential anti-tuberculosis agents. 146
Design, synthesis and biological evaluation of new pyrazolyl-ureas and imidazopyrazolecarboxamides able to interfere with MAPK and PI3K upstream signaling involved in the angiogenesis 134
3-Cyclopentyloxy-4-Methoxyphenyl-isoxazoline derivatives as new PDE4 inhibitors. 128
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 106
Development of imidazo-pyrazole derivatives as potential antimetastatic agents in neuroblastoma 99
The kinase inhibitor pyrazolyl-urea GeGe3 inhibits angiogenesis and reveals dystrophia myotonica protein kinase (DMPK)1 as a novel angiogenesis target 89
The Kinase Inhibitor Pyrazolyl-Urea Gege3 Inhibits Angiogenesis And Reveals Dystrophia Myotonica Protein Kinase (DMPK)1 As A Novel Angiogenesis Target 76
New series of pyrazoles and imidazo‐pyrazoles targeting different cancer and inflammation pathways 74
New kinases targeted compounds as possible antiangiogenic and antimetastatic agents 63
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 57
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds 34
null 18
Totale 1.177
Categoria #
all - tutte 4.685
article - articoli 3.633
book - libri 0
conference - conferenze 1.052
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 9 3 10 6 8 4 1
2021/2022115 10 5 2 8 4 8 2 33 13 15 0 15
2022/2023149 11 17 2 22 20 18 0 13 14 0 27 5
2023/202489 4 14 2 15 19 9 5 2 2 4 2 11
2024/2025269 4 25 3 26 29 21 24 46 11 11 31 38
2025/2026200 57 9 18 25 82 9 0 0 0 0 0 0
Totale 1.177